astragaloside a has been researched along with calpain inhibitor iii in 1 studies
| Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) | Studies (calpain inhibitor iii) | Trials (calpain inhibitor iii) | Recent Studies (post-2010) (calpain inhibitor iii) |
|---|---|---|---|---|---|
| 675 | 5 | 573 | 187 | 0 | 76 |
| Protein | Taxonomy | astragaloside a (IC50) | calpain inhibitor iii (IC50) |
|---|---|---|---|
| Calpain-9 | Homo sapiens (human) | 1.61 | |
| Calpain-1 catalytic subunit | Homo sapiens (human) | 0.183 | |
| Procathepsin L | Homo sapiens (human) | 0.6365 | |
| Cathepsin B | Homo sapiens (human) | 0.5186 | |
| Calpain-2 catalytic subunit | Homo sapiens (human) | 0.35 | |
| Calpain-1 catalytic subunit | Sus scrofa (pig) | 0.02 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.1 | |
| Falcipain 2B | Plasmodium falciparum (malaria parasite P. falciparum) | 5 | |
| Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leng, B; Nie, Q; Wang, H; Zhang, L; Zhu, L | 1 |
1 other study(ies) available for astragaloside a and calpain inhibitor iii
| Article | Year |
|---|---|
Astragaloside IV protects against hyperglycemia-induced vascular endothelial dysfunction by inhibiting oxidative stress and Calpain-1 activation.
Topics: Acetylcysteine; Animals; Aorta, Thoracic; Biomarkers; Calpain; Cysteine Proteinase Inhibitors; Diabetes Mellitus, Experimental; Dipeptides; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Hyperglycemia; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Sprague-Dawley; Saponins; Streptozocin; Triterpenes; Vasodilation | 2019 |